The Dialogues are available in webcast and podcast formats below after the live broadcast. The podcast format works well for listening during commute, drive, or leisure because the Dialogues are conversations and do not contain any slides. Please keep in mind that COVID-19 information changes rapidly, and the webcasts and podcasts have a limited shelf life.
iTunes® or your favorite MP3 audio player is required to listen to the podcast audio files. If you do not have iTunes® installed on your computer, you can download the free software on the Apple Web site.
(December 3, 2021) Update on COVID-19 in People Who Are Immunocompromised, Waning Immunity, Breakthrough Infection, and Booster Shots
Moderator: Paul A. Volberding, MD (University of California San Francisco)
Discussants: Yvonne Maldonado, MD (Stanford University), Peter Chin-Hong, MD (University of California San Francisco) and, Carlos del Rio, MD (Emory University School of Medicine)
(October 22, 2021) Update on COVID-19 in People Who Are Immunocompromised, Waning Immunity, Breakthrough Infection, and Booster Shots
Moderator: Paul A. Volberding, MD (University of California San Francisco)
Discussants: Yvonne Maldonado, MD (Stanford University), Peter Chin-Hong, MD (University of California San Francisco) and, Carlos del Rio, MD (Emory University School of Medicine)
(June 18, 2021) SARS-CoV-2 Variants: Where Did They Come From and Where Are They Going
Discussants: Michael S. Saag, MD, and Penny Moore
(June 1, 2021) Up to Date on COVID-19: Expert Discussion
Discussants: George Rutherford, MD, and Paul A. Volberding, MD
(April 13, 2021) Update on Early Treatment of COVID-19
Discussants: Kara W. Chew, MD, MS, and Judith S. Currier, MD
(February 10, 2021) The Latest on “COVID-19 Meets HIV”: Variants, Vaccines, Health Disparities, and Other Fast-Evolving Issues
Discussants: Wendy Armstrong, MD, and Carlos del Rio, MD
(January 29, 2021) Update on SARS-CoV-2 Variants, the Status of Vaccine Development, and Decreasing the Case Rate–What Does it Mean?
Discussants: George Rutherford, MD, and Paul A. Volberding, MD
(January 4, 2021) Update on COVID-19 Vaccines
Discussants: Michael S. Saag, MD, and Mark J. Mulligan, MD
(November 23, 2020) When the Going Gets Tough, the Tough Keep Going: Impact of the COVID-19 Pandemic on Hepatitis C and STI Testing and Care
Discussants: Meredith E. Clement, MD, and Susanna Naggie, MD, MHS
(October 19, 2020) Lessons From the Lab: Implications for Coronavirus Vaccine and Therapeutics Research and Development
Discussants: Robert T. Schooley, MD, Joseph J. Eron, Jr, MD, and Ralph S. Baric, PhD
(September 23, 2020) Addressing Questions About COVID-19
Discussants: Rajesh T. Gandhi, MD, and Monica Gandhi, MD, MPHG
(September 15, 2020) HIV and COVID-19 Interactions and Parallels in Advocacy
Discussants: Peter Chin-Hong, MD, and Paul A. Volberding, MD
(September 9, 2020) New Strategies and Challenges of PrEP in the COVID-19 Era
Discussants: Raphael J. Landovitz, MD, and E. Turner Overton, MD
(August 19, 2020) Continued Discussion on COVID-19 Epidemiology and Transmission
Discussants: George Rutherford, MD, and Paul A. Volberding, MD
(July 31, 2020) Current Status of COVID-19 Treatment and Vaccine Research
Discussants: Michael S. Saag, MD, and Robert T. Schooley, MD
(July 22, 2020) Insights From AIDS 2020/COVID-19 at IAS, Updates on COVID-19, and the Interplay Between HIV and COVID-19
Discussants: Rajesh T. Gandhi, MD, and Monica Gandhi, MD, MPHG
(June 30, 2020) COVID-19 Meets HIV: Focus on Health Disparities
Discussants: Wendy Armstrong, MD, and Carlos del Rio, MD
(June 17, 2020) COVID-19 in Women
Discussants: Judith S. Currier, MD, and Jeanne M. Marrazzo, MD
(June 10, 2020) COVID-19 Public Health Updates
Discussants: George Rutherford, MD, and Paul A. Volberding, MD